Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.

Perivascular CD73+ cells attenuate inflammation and interstitial fibrosis in the kidney microenvironment.

Perry HM, Görldt N, Sung SJ, Huang L, Rudnicka KP, Encarnacion IM, Bajwa A, Tanaka S, Poudel N, Yao J, Rosin DL, Schrader J, Okusa MD.

Am J Physiol Renal Physiol. 2019 Sep 1;317(3):F658-F669. doi: 10.1152/ajprenal.00243.2019. Epub 2019 Jul 31.

PMID:
31364375
2.

Role of Natural IgM and IgM Induced Bregs in Preventing Ischemia Induced Innate Inflammation and Acute Kidney Injury.

Lobo PI, Okusa MD.

Nephron. 2019 Jul 9:1-4. doi: 10.1159/000501639. [Epub ahead of print] Review.

3.

Pannexins in Acute Kidney Injury.

Poudel N, Okusa MD.

Nephron. 2019 Jun 26:1-4. doi: 10.1159/000501278. [Epub ahead of print] Review.

4.

Non-canonical cholinergic anti-inflammatory pathway-mediated activation of peritoneal macrophages induces Hes1 and blocks ischemia/reperfusion injury in the kidney.

Inoue T, Abe C, Kohro T, Tanaka S, Huang L, Yao J, Zheng S, Ye H, Inagi R, Stornetta RL, Rosin DL, Nangaku M, Wada Y, Okusa MD.

Kidney Int. 2019 Mar;95(3):563-576. doi: 10.1016/j.kint.2018.09.020. Epub 2019 Jan 19.

PMID:
30670317
5.

AKI and the Neuroimmune Axis.

Tanaka S, Okusa MD.

Semin Nephrol. 2019 Jan;39(1):85-95. doi: 10.1016/j.semnephrol.2018.10.008. Review.

PMID:
30606410
6.

Bioelectronic Approaches to Control Neuroimmune Interactions in Acute Kidney Injury.

Inoue T, Tanaka S, Rosin DL, Okusa MD.

Cold Spring Harb Perspect Med. 2019 Jun 3;9(6). pii: a034231. doi: 10.1101/cshperspect.a034231. Review.

PMID:
30126836
7.

Optogenetics in Understanding Mechanisms of Acute Kidney Injury.

Tanaka S, Okusa MD.

Nephron. 2018;140(2):152-155. doi: 10.1159/000491498. Epub 2018 Jul 10. Review.

8.

Epithelial and Endothelial Pannexin1 Channels Mediate AKI.

Jankowski J, Perry HM, Medina CB, Huang L, Yao J, Bajwa A, Lorenz UM, Rosin DL, Ravichandran KS, Isakson BE, Okusa MD.

J Am Soc Nephrol. 2018 Jul;29(7):1887-1899. doi: 10.1681/ASN.2017121306. Epub 2018 Jun 4.

9.

Metabolic Syndrome Severity and Risk of CKD and Worsened GFR: The Jackson Heart Study.

DeBoer MD, Filipp SL, Musani SK, Sims M, Okusa MD, Gurka M.

Kidney Blood Press Res. 2018;43(2):555-567. doi: 10.1159/000488829. Epub 2018 Apr 6.

10.

Overcoming Translational Barriers in Acute Kidney Injury: A Report from an NIDDK Workshop.

Zuk A, Palevsky PM, Fried L, Harrell FE Jr, Khan S, McKay DB, Devey L, Chawla L, de Caestecker M, Kaufman JS, Thompson BT, Agarwal A, Greene T, Okusa MD, Bonventre JV, Dember LM, Liu KD, Humphreys BD, Gossett D, Xie Y, Norton JM, Kimmel PL, Star RA.

Clin J Am Soc Nephrol. 2018 Jul 6;13(7):1113-1123. doi: 10.2215/CJN.06820617. Epub 2018 Mar 9.

11.

Conditional MitoTimer reporter mice for assessment of mitochondrial structure, oxidative stress, and mitophagy.

Wilson RJ, Drake JC, Cui D, Zhang M, Perry HM, Kashatus JA, Kusminski CM, Scherer PE, Kashatus DF, Okusa MD, Yan Z.

Mitochondrion. 2019 Jan;44:20-26. doi: 10.1016/j.mito.2017.12.008. Epub 2017 Dec 20.

12.

Dynamin-Related Protein 1 Deficiency Promotes Recovery from AKI.

Perry HM, Huang L, Wilson RJ, Bajwa A, Sesaki H, Yan Z, Rosin DL, Kashatus DF, Okusa MD.

J Am Soc Nephrol. 2018 Jan;29(1):194-206. doi: 10.1681/ASN.2017060659. Epub 2017 Oct 30.

13.

Targeting neural reflex circuits in immunity to treat kidney disease.

Okusa MD, Rosin DL, Tracey KJ.

Nat Rev Nephrol. 2017 Nov;13(11):669-680. doi: 10.1038/nrneph.2017.132. Epub 2017 Oct 3. Review.

14.

Natural IgM and TLR Agonists Switch Murine Splenic Pan-B to "Regulatory" Cells That Suppress Ischemia-Induced Innate Inflammation via Regulating NKT-1 Cells.

Lobo PI, Schlegel KH, Bajwa A, Huang L, Okusa MD.

Front Immunol. 2017 Aug 23;8:974. doi: 10.3389/fimmu.2017.00974. eCollection 2017.

15.

Neuroimmune Interactions in Inflammation and Acute Kidney Injury.

Inoue T, Tanaka S, Okusa MD.

Front Immunol. 2017 Aug 9;8:945. doi: 10.3389/fimmu.2017.00945. eCollection 2017. Review.

16.

Nonpharmacological, Biomechanical Approaches to Control Inflammation in Acute Kidney Injury.

Tanaka S, Inoue T, Hossack JA, Okusa MD.

Nephron. 2017;137(4):277-281. doi: 10.1159/000477218. Epub 2017 Jun 9. Review.

17.

IL233, A Novel IL-2 and IL-33 Hybrid Cytokine, Ameliorates Renal Injury.

Stremska ME, Jose S, Sabapathy V, Huang L, Bajwa A, Kinsey GR, Sharma PR, Mohammad S, Rosin DL, Okusa MD, Sharma R.

J Am Soc Nephrol. 2017 Sep;28(9):2681-2693. doi: 10.1681/ASN.2016121272. Epub 2017 May 24.

18.

C1 neurons mediate a stress-induced anti-inflammatory reflex in mice.

Abe C, Inoue T, Inglis MA, Viar KE, Huang L, Ye H, Rosin DL, Stornetta RL, Okusa MD, Guyenet PG.

Nat Neurosci. 2017 May;20(5):700-707. doi: 10.1038/nn.4526. Epub 2017 Mar 13.

19.

Dependence of Glomerulonephritis Induction on Novel Intraglomerular Alternatively Activated Bone Marrow-Derived Macrophages and Mac-1 and PD-L1 in Lupus-Prone NZM2328 Mice.

Sung SJ, Ge Y, Dai C, Wang H, Fu SM, Sharma R, Hahn YS, Yu J, Le TH, Okusa MD, Bolton WK, Lawler JR.

J Immunol. 2017 Apr 1;198(7):2589-2601. doi: 10.4049/jimmunol.1601565. Epub 2017 Feb 20.

20.

Optimal Role of the Nephrologist in the Intensive Care Unit.

Askenazi DJ, Heung M, Connor MJ Jr, Basu RK, Cerdá J, Doi K, Koyner JL, Bihorac A, Golestaneh L, Vijayan A, Okusa MD, Faubel S; American Society of Nephrology Acute Kidney Injury Advisory Group.

Blood Purif. 2017;43(1-3):68-77. doi: 10.1159/000452317. Epub 2016 Dec 3.

21.

Endothelial Sphingosine 1‑Phosphate Receptor‑1 Mediates Protection and Recovery from Acute Kidney Injury.

Perry HM, Huang L, Ye H, Liu C, Sung SJ, Lynch KR, Rosin DL, Bajwa A, Okusa MD.

J Am Soc Nephrol. 2016 Nov;27(11):3383-3393. Epub 2016 Mar 9.

22.

Sphingosine Kinase 2 Deficiency Attenuates Kidney Fibrosis via IFN-γ.

Bajwa A, Huang L, Kurmaeva E, Ye H, Dondeti KR, Chroscicki P, Foley LS, Balogun ZA, Alexander KJ, Park H, Lynch KR, Rosin DL, Okusa MD.

J Am Soc Nephrol. 2017 Apr;28(4):1145-1161. doi: 10.1681/ASN.2016030306. Epub 2016 Oct 31.

23.

Endothelial Dysfunction in Renal Interstitial Fibrosis.

Perry HM, Okusa MD.

Nephron. 2016;134(3):167-171. Epub 2016 Aug 30. Review.

24.

The Influence of Hemodialysis on T Regulatory Cells: A Meta-Analysis and Systematic Review.

Caprara C, Kinsey GR, Corradi V, Xin W, Ma JZ, Scalzotto E, Martino FK, Okusa MD, Nalesso F, Ferrari F, Rosner M, Ronco C.

Blood Purif. 2016;42(4):307-313. Epub 2016 Oct 1.

25.

Proximal Tubule CD73 Is Critical in Renal Ischemia-Reperfusion Injury Protection.

Sung SJ, Li L, Huang L, Lawler J, Ye H, Rosin DL, Vincent IS, Le TH, Yu J, Görldt N, Schrader J, Okusa MD.

J Am Soc Nephrol. 2017 Mar;28(3):888-902. doi: 10.1681/ASN.2016020229. Epub 2016 Sep 14.

26.

CAPing inflammation and acute kidney injury.

Inoue T, Rosin DL, Okusa MD.

Kidney Int. 2016 Sep;90(3):462-5. doi: 10.1016/j.kint.2016.07.009.

PMID:
27521104
27.

Vagus nerve stimulation mediates protection from kidney ischemia-reperfusion injury through α7nAChR+ splenocytes.

Inoue T, Abe C, Sung SS, Moscalu S, Jankowski J, Huang L, Ye H, Rosin DL, Guyenet PG, Okusa MD.

J Clin Invest. 2016 May 2;126(5):1939-52. doi: 10.1172/JCI83658. Epub 2016 Apr 18.

28.

Enhancing Nephrology Career Interest through the ASN Kidney TREKS Program.

Maursetter LJ, Stern LD, Sozio SM, Patel AB, Rao R, Shah HH, Leight K, Okusa MD, Zeidel ML, Parker MG.

J Am Soc Nephrol. 2016 Jun;27(6):1604-7. doi: 10.1681/ASN.2015101086. Epub 2016 Mar 29.

29.

The Nephrologist's Tumor: Basic Biology and Management of Renal Cell Carcinoma.

Hu SL, Chang A, Perazella MA, Okusa MD, Jaimes EA, Weiss RH; American Society of Nephrology Onco-Nephrology Forum.

J Am Soc Nephrol. 2016 Aug;27(8):2227-37. doi: 10.1681/ASN.2015121335. Epub 2016 Mar 9. Review.

30.

Acute Kidney Injury Prevention.

Chopra TA, Brooks CH, Okusa MD.

Contrib Nephrol. 2016;187:9-23. doi: 10.1159/000443152. Epub 2016 Feb 8. Review.

PMID:
26881939
31.

Driving change: kidney proximal tubule CSF-1 polarizes macrophages.

Perry HM, Okusa MD.

Kidney Int. 2015 Dec;88(6):1219-1221. doi: 10.1038/ki.2015.324.

32.

Bridging Translation by Improving Preclinical Study Design in AKI.

de Caestecker M, Humphreys BD, Liu KD, Fissell WH, Cerda J, Nolin TD, Askenazi D, Mour G, Harrell FE Jr, Pullen N, Okusa MD, Faubel S; ASN AKI Advisory Group.

J Am Soc Nephrol. 2015 Dec;26(12):2905-16. doi: 10.1681/ASN.2015070832. Epub 2015 Nov 4. Review.

33.

Natural IgM Switches the Function of Lipopolysaccharide-Activated Murine Bone Marrow-Derived Dendritic Cells to a Regulatory Dendritic Cell That Suppresses Innate Inflammation.

Lobo PI, Schlegel KH, Bajwa A, Huang L, Kurmaeva E, Wang B, Ye H, Tedder TF, Kinsey GR, Okusa MD.

J Immunol. 2015 Dec 1;195(11):5215-26. doi: 10.4049/jimmunol.1500052. Epub 2015 Oct 30.

34.

Therapeutic Targets of Human AKI: Harmonizing Human and Animal AKI.

Okusa MD, Rosner MH, Kellum JA, Ronco C; Acute Dialysis Quality Initiative XIII Workgroup.

J Am Soc Nephrol. 2016 Jan;27(1):44-8. doi: 10.1681/ASN.2015030233. Epub 2015 Oct 30.

35.

Renal Hemodynamics in AKI: In Search of New Treatment Targets.

Matejovic M, Ince C, Chawla LS, Blantz R, Molitoris BA, Rosner MH, Okusa MD, Kellum JA, Ronco C; ADQI XIII Work Group.

J Am Soc Nephrol. 2016 Jan;27(1):49-58. doi: 10.1681/ASN.2015030234. Epub 2015 Oct 28.

36.

Association Analysis of the Reticulon 1 Gene in End-Stage Kidney Disease.

Bonomo JA, Palmer ND, He JC, Fan Y, Hicks PJ, Lea JP, Okusa MD, Bowden DW, Freedman BI.

Am J Nephrol. 2015;42(4):259-64. doi: 10.1159/000441199. Epub 2015 Oct 24.

37.

Neuroimmune Control of Acute Kidney Injury and Inflammation.

Inoue T, Okusa MD.

Nephron. 2015;131(2):97-101. doi: 10.1159/000438496. Epub 2015 Sep 17. Review.

38.

Sphingosine 1-Phosphate Receptor 3-Deficient Dendritic Cells Modulate Splenic Responses to Ischemia-Reperfusion Injury.

Bajwa A, Huang L, Kurmaeva E, Gigliotti JC, Ye H, Miller J, Rosin DL, Lobo PI, Okusa MD.

J Am Soc Nephrol. 2016 Apr;27(4):1076-90. doi: 10.1681/ASN.2015010095. Epub 2015 Aug 18.

39.

Outpatient Dialysis for Patients with AKI: A Policy Approach to Improving Care.

Heung M, Faubel S, Watnick S, Cruz DN, Koyner JL, Mour G, Liu KD, Cerda J, Okusa MD, Lukaszewski M, Vijayan A; American Society of Nephrology Acute Kidney Injury Advisory Group.

Clin J Am Soc Nephrol. 2015 Oct 7;10(10):1868-74. doi: 10.2215/CJN.02290215. Epub 2015 Jul 28. Review.

40.

Promoting Kidney Function Recovery in Patients with AKI Requiring RRT.

Cerdá J, Liu KD, Cruz DN, Jaber BL, Koyner JL, Heung M, Okusa MD, Faubel S; AKI Advisory Group of the American Society of Nephrology.

Clin J Am Soc Nephrol. 2015 Oct 7;10(10):1859-67. doi: 10.2215/CJN.01170215. Epub 2015 Jul 2. Review.

41.

Adenosine 2A receptors in acute kidney injury.

Vincent IS, Okusa MD.

Acta Physiol (Oxf). 2015 Jul;214(3):303-10. doi: 10.1111/apha.12508. Epub 2015 May 19. Review.

42.

Emerging therapeutic targets of sepsis-associated acute kidney injury.

Swaminathan S, Rosner MH, Okusa MD.

Semin Nephrol. 2015 Jan;35(1):38-54. doi: 10.1016/j.semnephrol.2015.01.005. Review.

43.

Recovery from acute kidney injury: predicting outcomes.

Abdel-Rahman EM, Okusa MD.

Am J Kidney Dis. 2015 Apr;65(4):528-9. doi: 10.1053/j.ajkd.2015.02.316. No abstract available.

PMID:
25791960
44.

Hepcidin Mitigates Renal Ischemia-Reperfusion Injury by Modulating Systemic Iron Homeostasis.

Scindia Y, Dey P, Thirunagari A, Liping H, Rosin DL, Floris M, Okusa MD, Swaminathan S.

J Am Soc Nephrol. 2015 Nov;26(11):2800-14. doi: 10.1681/ASN.2014101037. Epub 2015 Mar 18.

45.

Ultrasound Modulates the Splenic Neuroimmune Axis in Attenuating AKI.

Gigliotti JC, Huang L, Bajwa A, Ye H, Mace EH, Hossack JA, Kalantari K, Inoue T, Rosin DL, Okusa MD.

J Am Soc Nephrol. 2015 Oct;26(10):2470-81. doi: 10.1681/ASN.2014080769. Epub 2015 Feb 2.

46.

The spleen: the forgotten organ in acute kidney injury of critical illness.

Gigliotti JC, Okusa MD.

Nephron Clin Pract. 2014;127(1-4):153-7. doi: 10.1159/000363255. Epub 2014 Sep 24. Review.

47.

Effects of aging on renal function and regenerative capacity.

Abdel-Rahman EM, Okusa MD.

Nephron Clin Pract. 2014;127(1-4):15-20. doi: 10.1159/000363708. Epub 2014 Sep 24. Review.

48.

Biology of renal recovery: molecules, mechanisms, and pathways.

Vincent IS, Okusa MD.

Nephron Clin Pract. 2014;127(1-4):10-4. doi: 10.1159/000363714. Epub 2014 Sep 24. Review.

49.

Lack of Association of the APOL1 G3 Haplotype in African Americans with ESRD.

Palmer ND, Ng MC, Langefeld CD, Divers J, Lea JP, Okusa MD, Kimberly RP, Bowden DW, Freedman BI.

J Am Soc Nephrol. 2015 May;26(5):1021-5. doi: 10.1681/ASN.2014050444. Epub 2014 Sep 23.

50.

Sphingosine 1-phosphate receptor-1 enhances mitochondrial function and reduces cisplatin-induced tubule injury.

Bajwa A, Rosin DL, Chroscicki P, Lee S, Dondeti K, Ye H, Kinsey GR, Stevens BK, Jobin K, Kenwood BM, Hoehn KL, Lynch KR, Okusa MD.

J Am Soc Nephrol. 2015 Apr;26(4):908-25. doi: 10.1681/ASN.2013121351. Epub 2014 Aug 21.

Supplemental Content

Loading ...
Support Center